by Chaar Yeates | Nov 12, 2018 | Benefits of Qimono, Qimono
Tests to evaluate the compatibility of Qimono, Vygon’s closed system transfer device, with key cancer therapies have concluded the connectors would be compatible with all cytotoxic drug infusions in current clinical practice. The testing conducted by Professor Graham...
by Chaar Yeates | Nov 12, 2018 | Qimono
A new clinical study from the US shows a reduction in contamination risk of 97% when using a closed system transfer device (CSTD) to administer hazardous drugs. The US study* involved 13 cancer centres across the United States and the findings demonstrated that the...
by Chaar Yeates | Nov 12, 2018 | Qimono, SACTsafety
A yellow cover document from the NHS Specialist Pharmacy Service proposes a nine-point plan to minimise exposure to potentially dangerous systemic anti-cancer therapies. The ‘Guidance on Handling of Injectable Cytotoxic Drugs in Clinical Areas in NHS Hospitals in the...
by MarketingWP-Admin | Oct 19, 2018 | Qimono, Supporting papers for CSTD
A new poster from Pr Graham Sewell (Plymouth University) showing the physical & chemical inertness of Qimono, when exposed to seven aggressive cytotoxic drugs. Pr Sewell states in his conclusion that based on his work, it’s reasonable to conclude that Qimono...
by MarketingWP-Admin | Jun 7, 2018 | Qimono, SACTsafety
Alison Simons and Samantha Toland from Birmingham City University (BCU) have been generating a bit of a buzz over the last few years when it comes to highlighting the potential risks healthcare workers face when delivering chemotherapy to patients. Acting as the...
by MarketingWP-Admin | Jun 7, 2018 | Benefits of Qimono, Qimono
Qimono is a totally closed system drug transfer device specially designed to be safe and easy to use by pharmacists and nurses. It is widely documented that exposure to Systemic Anti-Cancer Therapy (SACT), can pose a significant health risk to patients during...
